By Frank Hartzell A company that provides analytical tools to biotech companies saw shares rise for 10 months straight during pandemic. You might not guess from its stock chart, but a technology supplier to the biotech industry recently argued to Jim Cramer that it’s not pandemic driven. Dr. Udit Batra, president and CEO of Waters Corp. (WAT) – Get Waters Corporation Report, explained to Jim Cramer on a recent episode of the Mad Money TV show that while the firm was involved in vaccine and therapeutic development, the vast majority of their earnings are not Covid-related. Waters is an analytic…